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Heterogeneity in type XI procollagen structure is ex-
tensive because all three a(XI) collagen genes undergo
complex alternative splicing within the amino-propep-
tide coding domain. Exon 7 of the human and exons 6–8
of the mouse a2(XI) collagen genes, encoding part of the
amino-propeptide variable region, have recently been
shown to be alternatively spliced. We show that exon
6-containing mRNAs for human a2(XI) procollagen are
expressed at 28 weeks in fetal tendon and cartilage but
not at 38–44 days or 11 weeks. In the mouse, exon 6 is
expressed in chondrocytes from 13.5 days onward. We
recently identified conserved sequences within intron 6
of the human and mouse a2(XI) collagen genes, contain-
ing additional consensus splice acceptor and donor sites
that potentially increase the size of exon 7, dividing it
into three parts, designated 7A, 7B, and 7C. We show by
reverse transcription polymerase chain reaction and in
situ hybridization that these potential splice sites are
used to yield additional a2(XI) procollagen mRNA splice
variants that are expressed in fetal tissues. In human,
expression of exon 7B-containing transcripts may be
developmental stage-specific. Interestingly, inclusion of
exon 7A or exon 7B in human and mouse a2(XI) procol-
lagenmRNAs, respectively, would result in the insertion
of an in-frame termination codon, suggesting that some
of the additional splice variants encode a truncated pro-
a2(XI) chain.
The collagens are an important class of extracellular matrix
components because the structural integrity and functional
properties of different tissues are influenced by the character-
istic combinations and amounts of these molecules (1). These
triple helical glycoprotein molecules belong to a large family
consisting of 19 different types with 30 genes encoding their
constituent a chains (2, 3). Diversity within a single type of
collagen can arise not only through varying the combinations of
their a chains within heterotrimers, but also from the synthesis
of different isoforms arising from alternative splicing of
mRNAs. There is increasing evidence for the syntheses of dif-
ferent isoforms within each collagen type arising from alterna-
tively spliced transcripts such as for types II, VI, IX, XI, XIII,
XIV, and XVIII collagens (4–7). In addition, alternative splic-
ing of a2(I) and a1(III) collagen genes produces mRNAs that
could encode a non-collagenous protein and/or truncated colla-
gen, suggesting that some collagen genes may have alternative
functions (8, 9).
Type XI collagen, a fibril-forming collagen, is a heterotrimer
composed of a1(XI), a2(XI), and a3(XI) subunits (10) and is
synthesized as a precursor procollagen molecule with amino-
and carboxyl-terminal globular extensions (propeptides). The
amino-propeptides in both a1(XI) and a2(XI) procollagen con-
sist of several subdomains, a proline- and arginine-rich peptide
region (PARP),1 a variable region (VR), and a constant region
(CR). For both of these procollagens the PARP and CR subdo-
mains are similar in size, but the VR subdomain is highly
variable both in length and amino acid sequence, raising ques-
tions about possible different functional roles of the VR (11, 12).
We have recently found that heterogeneity in type XI colla-
gen structure may arise from differing combinations of the
three a(XI) chains within heterotrimers and homotrimers (13).
The heterogeneity in type XI procollagen structure may be
more extensive because all three genes for type XI collagen
have been shown to undergo alternative splicing within the
amino-propeptide coding domain. The VR in the amino-propep-
tide of a2(XI) procollagen is encoded by exons 5–9 in the gene.
Within this coding region, exon 7 of the human and exons 6–8
of the mouse a2(XI) collagen genes have been shown to undergo
complex alternative splicing (14, 15). Alternative processing
has also been demonstrated in the VR of a1(XI) procollagen in
human, chick, and rat (14, 16). The pro-a3(XI) chain of type XI
procollagen is an overglycosylated variant of pro-a1(II) and
therefore is the gene product of the a1(II) collagen gene (17).
Exon 2 of the a1(II) collagen gene is also alternatively spliced,
yielding two forms of a1(II) procollagen mRNAs which either
include or exclude an exon encoding a cysteine-rich domain in
the amino-propeptide (18). Assembly of the translation prod-
ucts of these different pro-a(XI) alternatively spliced tran-
scripts within type XI procollagen heterotrimers would result
in extensive heterogeneity in the structure of the amino-
propeptide of type XI procollagen.
The genomic organization, intron-exon boundaries, and se-
quence conservation for the amino-propeptide coding domain of
the human and mouse a2(XI) collagen genes have been deter-
mined recently, partly by comparing cDNA and genomic se-
quences (14, 15, 19) (Fig. 1). In assessing the degree of inter-
species sequence conservation for the a2(XI) collagen gene, we
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had noted a region of conserved sequences containing motifs
corresponding to consensus splice acceptor and donor sites
within intron 6 of the human and mouse genes (19). In the
present study, we have aimed to assess whether these splice
signals can function to generate alternative transcripts using
RT-PCR and in situ hybridization. We show that these poten-
tial splice sites are used to yield additional a2(XI) procollagen
mRNA splice variants that are expressed in human and mouse
fetal tissues. Interestingly, inclusion of one of these additional
exons in a2(XI) procollagen mRNAs would result in the inser-
tion of an in-frame termination codon within the VR, suggest-
ing that some of the additional splice variants encode a trun-
cated pro-a2(XI) chain.
EXPERIMENTAL PROCEDURES
Human Fetal Material
Human fetal tissues were obtained from elective therapeutic termi-
nations of pregnancy. Approval was obtained from the Ethical Commit-
tee of the Medical Faculty, Hong Kong University, for work with fresh
embryonic materials. The gestational age of specimens was determined
by assessing the centers of ossification (20) and the histologic charac-
teristics of the stained sections. The crown–rump length was also meas-
ured for intact fresh specimens (21).
DNA Sequencing and Sequence Analyses
Nucleotide sequences were determined on both strands by the
dideoxy chain termination method (22) on double-stranded DNA using
Sequenase 2.0 (U. S. Biochemical Corp.) following the manufacturer’s
protocol. Longer contiguous stretches of DNA sequence were obtained
using the exonuclease/mungbean nuclease method of generating over-
lapping clones (23). Sequence comparison analyses were performed
using the UWGCG computer program (24).
Oligonucleotide Primers
The following pairs of oligonucleotide primers were used for cDNA
synthesis and PCR. To facilitate cloning of the PCR products, a HindIII
adaptor (underlined) was added to the 59 ends of primers. The locations
of these primers are also shown in Figs. 1 and 2.
Amplification between Human Exons 5 and 7C—An exon 7C primer
(OVL142H), 59-GGCAAGAGGCTCGACTCCAGGA-39, was used for
cDNA synthesis. OVL142H and an exon 5 primer (OVL130U), 59-
GAGCCCAGAGATCTCCACAGCA-39, were used for first round PCR.
Second round PCR was carried out using an exon 5 primer (OVL130R),
59-AAAAGCTTATCAGGAACCCCAGAGCCAG-39, and another exon 7C
primer (OVL131), 59-AAAAGCTTCTCTTCACCTGGGGTGGGGT-39.
Human Exons 5 to 7A—An exon 7A primer (OVL202), 59-GCAGTT-
GGAGAGGGCCTCCGG-39, was used for cDNA synthesis. OVL202 and
OVL130U were used for first round PCR. An exon 7A primer (OVL203),
59-AAAAGCTTGCAGGTGGGGTAGGCTTTCA-39, and OVL130R were
used for second round PCR.
Human Exons 5 to 7B—An exon 7B primer (OVL204), 59-GGA-
AATCTCAGATCTTGCAGCCCC-39, was used for cDNA synthesis.
OVL204 and OVL130U were used for first round PCR. Second round
PCR primers were OVL130R and OVL205, 59-AAAAGCTTGGGGA-
GAGTGAACCTCCAAG-39.
OVL172 (59-ACCTTGGAGGTTCACTCTCC-39)—This was used as an
exon 7B primer in conjunction with OVL131 in PCR to generate a
human exon 7B probe for in situ hybridization.
Mouse Exons 5 to 7C—An exon 7C primer (OVL142), 59-AAAAGCT-
TGGCAAGGGACTGGACTCCAG-39, was used for cDNA synthesis.
OVL142 and an exon 5 primer (OVL140), 59-AAAAGCTTGTTCAG-
GAGCTCCTCGTTGT-39, was used for first round PCR. Primers used
for the second round PCR amplification were OVL141 (59-AAAAGCT-
TCAGGAGCCCCAGAAGCAGGT-39, exon 5 primer) and OVL131.
OVL131 was used as a common exon 7C primer for the mouse and
human genes because this sequence was 100% conserved.
Cloning of RT-PCR Products
First strand cDNA was transcribed from 20 mg of total human RNA
or 10 mg of total mouse RNA using avian myeloblastosis virus reverse
transcriptase (35 units, Seikagaku America Inc. or 200 units, Super-
script II, Life Technologies, Inc.) with a corresponding antisense primer
as described previously (25). One-tenth of the reaction product was used
for second strand DNA synthesis and amplification by PCR with the
corresponding 59 sense primer. PCRs were carried out with 1-min
denaturation of DNA at 94 °C, 1-min annealing reaction at 55 °C, 1-min
extension reaction at 72 °C for 30 cycles. As controls, PCRs were per-
formed with same set of RNAs but without the addition of reverse
transcriptase to test for genomic contamination of RNA samples. Sec-
ond round PCR amplifications were performed with one-fifteenth of the
first round amplified products. The PCR amplifications were carried out
under the same conditions as the first round PCR amplification reac-
tions. RT-PCR products were either directly cloned into the EcoRV site
of pUBS (gift of G. Murphy, AFRC, Norwich) or digested with HindIII
(New England Biolabs) and subcloned into the HindIII site of pBlue-
scribe (Stratagene).
Southern Hybridization Analyses
Southern hybridizations using DNA probes labeled with [a-32P]dCTP
(Amersham Corp., 3,000 Ci/mmol) were at 65 °C for 18 h in a mixture
containing 3 3 SSC, 0.1% SDS, 12% polyethylene glycol 8000 (Sigma),
250 mg/ml heparin (Sigma grade II) (1 3 SSC: 0.15 M NaCl, 0.15 M
sodium citrate, pH 7.5), with posthybridization washes in 1 3 SSC,
0.1% SDS at 65 °C for human RT-PCR samples and in 0.1 3 SSC, 0.1%
SDS at 65 °C for mouse samples.
RNA Isolation and in Situ Hybridization
Total human and mouse RNAs were prepared by the lithium chlo-
ride-urea differential precipitation method (26). RNAs were isolated
from week 11 human fetal cartilage and from week 28 human fetal
cartilage and tendon. Mouse RNAs were isolated from 1-day-old neona-
tal cartilage and from day 15.5 whole mouse fetuses. Two human
fetuses of 38–42 days and 42–44 days gestation and day 16.5 CBA/n
mouse fetuses were collected and processed for in situ hybridization as
described (27). Single-stranded 35S-labeled sense and antisense ribo-
probes were generated from subclones containing human and mouse
pro-a2(XI) collagen gene exons as described previously (25).
Riboprobes
Riboprobes for the human a2(XI) collagen gene (COL11A2) were as
follows.
FIG. 1.Exon-intron organization of gene region coding the amino-propeptide of human a2(XI) collagen. Exons are shown in boxes and
are numbered from the 59 of the COL11A2 gene. Filled boxes represent exons or part of exons that encode Gly-X-Y sequences. Alternatively spliced
exons characterized in this and other studies (14, 15, 19) are in italics and underlined. Symbols and abbreviations: bent arrow, position of
transcription start of the COL11A2 gene; filled downward arrow, the amino-protease cleavage site; horizontal filled arrows, location of sequences
analyzed and direction of sequencing; kb, kilobases; SP, signal peptide; NC3, non-collagenous domain 3; COL2, collagenous domain 2; NC2,
non-collagenous domain 2; COL1, central triple helical domain. Restriction enzyme sites: B, BamHI;H,HindIII; K, KpnI; Ps, PstI; X, XhoI; Y, XbaI.
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1. pVL50, a 0.6-kilobase PstI fragment containing COL11A2 exon
6, was subcloned into pBluescript KS1 (Stratagene).
2. pVL51, a 170-bp PstI fragment containing COL11A2 exon 7A,
was subcloned into pBluescript KS1.
3. pVL105, a probe for COL11A2 exon 7B, was a 215-bp PCR
fragment generated using primer pair OVL172 and OVL131,
which anneal to exons 7B and the 59 end of exon 7C of COL11A2,
respectively, and cloned into TA vector (Invitrogen).
Riboprobes for the mouse a2(XI) collagen gene (Col11a-2) were as
follows.
1. pVL100, a 130-bp RT-PCR fragment containing Col11a-2 exon 6,
was subcloned into pBluescribe.
2. pVL102, a 290-bp RT-PCR fragment containing Col11a-2 exon
7A, was subcloned into pBluescribe.
3. pVL103, a 490-bp RT-PCR fragment containing exons 7A and 7B
subcloned in pBluescribe, was used to generate a probe for Col11a-2
exon 7B. pVL103 contained a BglII site within exon 7B, 17 nucleo-
tides from the junction between exons 7A and 7B. To generate a
riboprobe specific for exon 7B, pVL103 was linearized at the BglII
site for the production of antisense transcripts.
In situ hybridization slides were stained in Harris hematoxylin and
eosin, and K5 photographic emulsion (Ilford) was used for autoradiog-
raphy. Photographs of in situ hybridizations were taken using Kodak
Ektachrome ASA 64 film on a Zeiss Axioskop microscope under dark-
field illumination.
RESULTS AND DISCUSSION
Additional Splice Sites Flanking Exon 7 within the Variable
Region Coding Domain—A comparison of the genomic se-
quences of the human and mouse a2(XI) collagen genes2 (19)
showed that there was little sequence conservation for the
introns between exons 5 and 7. An exception was a highly
conserved region in the intron sequence between exons 6 and 7,
immediately upstream of the splice junction of exon 7 (Fig. 2
and Table I). Interestingly, this conserved region contained
additional potential splice acceptor and donor sequences simi-
lar to the consensus splice site signals 59-T/CT/CTTT/CT/CT/
CT/CT/CNCAGuG-39 (acceptor) and 59-AGuGTA/GAGT-39 (do-
nor) (28). One site (site 1, 59-TCTCTGCTGCAGuCG-39 in
human, 59-TCTCTCACTGCAGuCG-39 in mouse) is located 450
and 476 bp upstream of the published splice acceptor site for
exon 7. The other site (site 2) is a potential donor site (59-
TTACCGGCAuGTAGAG-39 in human and 59-TCGGCAGuGT-
AGAG-39in mouse) 227 and 198 bp 59 of the exon 7 splice
acceptor site in human and mouse, respectively (Fig. 2). Two
2 V. C. H. Lui, L. J. Ng, E. W. Y. Sat, J. Nicholls, and K. S. E. Cheah,
unpublished data.
FIG. 2. Sequence conservation and
additional splice signals between ex-
ons 5 and 7 in the amino-propeptide
coding domains of the human and
mouse a2(XI) collagen genes. Se-
quence identity is indicated by the
dashes, and gaps introduced by the GAP
program to optimize alignment are repre-
sented by stops (. . . . .). Exon sequences
are in uppercase letters; intron sequences
are in lowercase letters. The translated
amino acid sequence is shown above and
below the DNA sequence and in bold up-
percase letters. Additional potential splice
consensus sequences are overlined and
numbered for exon 7A (site 1) and exon 7B
(site 2). Donor sequences similar to the
consensus splice site signals: site 1 is lo-
cated 450 (human) and 476 (mouse) bp
upstream of the published splice acceptor
site for exon 7; site 2 is a potential donor
site in human and 59 227 and 198 bp 59 of
the exon 7 splice acceptor site in human
and mouse, respectively. The putative lar-
iat sequence is underlined and in bold.
The stop codon of translation is indicated
by a star. The locations of oligonucleotide
primers that were used in the RT-PCR
analyses are indicated by horizontal ar-
rows above and below the DNA sequence.
x, sequence ambiguity not resolved even
after sequencing both strands of DNA.
The potential splicing regulating purine-
rich sequences (see “Discussion”) are
boxed.
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putative branch point sequences, essential for the formation of
the lariat intermediate in mRNA splicing, are present 32–42
nucleotides upstream of each of the exon 7 potential splice
acceptor sites (29), suggesting that these signals could be
functional.
Consequences of Utilizing Additional Splice Signals within
Intron 6 of the a2(XI) Collagen Gene—The presence of addi-
tional signals within intron 6 of the a2(XI) collagen gene po-
tentially increases the size of exon 7 and if used, would divide
it into three parts, which we have designated 7A, 7B, and 7C as
shown in Figs. 1 and 2. Exon 7C corresponds to the alterna-
tively spliced exon 7 reported previously in human and mouse
(14, 15). Utilization of 59 acceptor site 1 in conjunction with the
closest donor (site 2) would yield a separate exon 7A of 250 and
252 bp in human and mouse, respectively. Acceptor site 1 could
also be used in conjunction with the donor site at the 39 end of
exon 7C to yield an enlarged exon 7 consisting of parts A, B,
and C, 540 bp in size for human a2(XI) collagen mRNA (513 bp
for the mouse homolog). Since the sequence at the 59 end of part
7B was more typical of a donor site than an acceptor, splicing of
this exon as a separate exon was probably rare. The third splice
variation would result from the use of previously reported
splice signals for exon 7 flanking part C, yielding a separate
exon 7C of 63 bp (14, 15).
Translation of the combined sequences within parts A, B,
and C of exon 7 for the human gene revealed an open reading
frame, in-frame with that for a2(XI) procollagen, which ended
in exon 7A because of the presence of the termination codon
TGA. Exon 7B also contained a termination codon TAA. In the
mouse gene the open reading frame ended within exon 7B with
the termination codon TGA. The difference in length of the
open reading frame in human and mouse lies in the replace-
ment of the human TGA codon in exon 7A with CCA in the
mouse. There were no canonical polyadenylation signals within
the intron 7 sequence; however, cleavage and polyadenylation
of transcripts containing exon 7A/7B within intron 7 cannot be
excluded since in other genes RNA processing can occur even in
the absence of a clear consensus sequence (30).
The absence of an alternative long open reading frame in the
combined sequence of exons 1–7C suggests that human pro-
a2(XI) mRNAs containing exon 7A or 7B and mouse transcripts
containing exon 7B would encode a truncated a2(XI) procolla-
gen containing approximately two-thirds of the intact amino-
propeptide that terminates in the variable region. Since assem-
bly of trimeric procollagen molecules requires association of the
carboxyl-propeptides, these truncated pro-a2(XI) chains are
not expected to associate within trimers. Instead, a non-collag-
enous polypeptide of 312 and 395 amino acids would be syn-
thesized for human and mouse, respectively. However, in the
mouse alternatively spliced transcripts containing exon 7A and
not 7B would encode full-length pro-a2(XI) collagen chains. The
sequence identity between human and mouse for these alter-
native exons was high at the amino acid and nucleotide levels
(Table I), suggesting a functional role for the truncated pro-
a2(XI) chain.
Expression of Additional Splice Variants of Exon 7 in Human
and Mouse—Reverse transcription PCR and in situ hybridiza-
tion were used to determine if the potential additional splice
variants of exon 7 could be expressed in vivo in human and
mouse fetal tissues.
RT-PCR Analyses—RT-PCR assays using human fetal RNA
and oligonucleotide primers to exons 5 and 7C (see “Experi-
mental Procedures”) generated two fragments of 130 and 50 bp
from week 28 cartilage and tendon (Fig. 3A). Only the 50-bp
fragment was obtained from week 11 cartilage RNA. The sizes
of these fragments were consistent with an exon composition of
exon 5–6-7C (130 bp) and exon 5–7C (50 bp). The presence of
exon 6 within the 130-bp fragment was confirmed by hybrid-
ization with an exon 6-specific probe (pVL50; Fig. 3A). Further
confirmation of the exon composition of these fragments was
obtained by cloning and sequencing the RT-PCR fragments
(data not shown). Comparison of the RT-PCR sequence with
the human genomic sequence showed that the 130-bp fragment
contained exons 5–6-7C and the 50-bp fragment, exons 5–7C;
however, no RT-PCR fragments containing exons 7A and 7B
were obtained. Although alternative transcripts containing
exon 6 have been demonstrated in the mouse (15), expression in
human has not been reported (14).
To determine if the failure to detect exons 7A and 7B in the
RNA samples truly reflected their absence, primers specific to
exons 7A and 7B were also used for RT-PCR (see “Experimen-
tal Procedures”). No RT-PCR product was obtained using prim-
ers to exons 5 and 7B (data not shown); however, two fragments
of 190 and 110 bp were generated from week 28 cartilage and
tendon RNA using the exon 7A primer (Fig. 3B). For week 11
cartilage RNA only the 110-bp fragment was obtained (Fig.
3B). The 190-bp fragment could not be cloned because of the
trace amount of this fragment obtained; however, hybridization
of the 190-bp fragment with both exon 6- and exon 7A-specific
probes (Fig. 3B) is consistent with an exon 5–6-7A composition.
The 110-bp fragment contained exon 5–7A since it hybridized
only with the exon 7A probe and not exon 6. This predicted
composition of the 110-bp fragment was confirmed by cloning
and sequencing the RT-PCR product (data not shown). Since
the presence of the termination codon in exon 7A (Fig. 2),
predicted from the genomic sequence was confirmed, this frag-
ment represents a transcript encoding a truncated a2(XI) pro-
collagen. Although the relative amounts of the different exon
7-containing transcripts were not measured, in human,
mRNAs containing exon 7A were probably of low abundance at
the developmental stage studied, since they could only be re-
vealed using exon 7A-specific primers.
Total RNAs from mouse fetuses 15.5 days postcoitus and
from 1-day-old neonatal mouse cartilage were also analyzed by
RT-PCR using oligonucleotide primers to exons 5 and 7C (see
“Experimental Procedures”). For both RNA samples, amplified
products of 490, 290, and 130 bp were obtained (Fig. 4). These
fragments hybridized with probe pVL5E1, containing exons
5–7 of the human COL11A2 gene (Fig. 3), suggesting complex
alternative splicing within this region of the gene. The exon
composition within these fragments was determined by cloning
and sequencing the RT-PCR fragments (data not shown) and
by comparing the DNA sequences with the mouse genomic
sequence.
Sequence analyses of the cloned RT-PCR fragments revealed
that the compositions of the different fragments were as fol-
TABLE I
Comparison of exon sizes and sequence identity for the
amino-propeptide coding domain of the human and mouse
a2(XI) collagen gene
Exon Exon size
Identity
Amino acids Nucleotidesequences
bp %
5 (Ia) 192 78.1 78.6
6 78 (78c) 96.1 96.1
7A 250 (252c) 60 82.7
7B 227 (180c) 50 80.2
7C(IIa,7b) 63 (63c) 76.2 85.7
a Human COL11A2 exon number in Ref. 14.
b Mouse Col11a-2 exon number in Ref. 15.
c Exon size in Col11a-2 determined in this study.
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lows: the 490-bp fragment, exons 5–7A-7B-7C; the 290-bp frag-
ment, exons 5–7A-7C; and the 130-bp fragment, exons 5–6-7C
(data not shown). These analyses showed that mouse Col11a-2
exon 6 was 78 bp, in agreement with the previous report (15).
The sizes of exons 7A and 7B, 252 and 198 bp, respectively,
were as predicted from the genomic sequence (Fig. 2). Tran-
scripts containing exons 5–7B-7C were not detected as may be
expected if the junction of 7A and 7B acted mainly as a donor
site (Fig. 2). Because of the termination codon in exon 7B, the
transcript represented by the 490-bp fragment would encode
truncated a2(XI) procollagen.
In Situ Hybridization Analyses—The fetal tissue pattern of
expression of transcripts containing alternatively spliced exons
was studied by in situ hybridization using antisense riboprobes
specific for the each of the individual exons 6, 7A, or 7B (Fig. 5).
Hybridization signals were at background level for the sense
controls for all three riboprobes (reviewed, data not shown).
Despite the high sequence homology (80%) between human and
mouse exon 7B, background hybridization signals were ob-
tained for the day 42–44 human fetal tissues using the mouse
exon 7B probe. In contrast, a strong hybridization signal was
obtained in the vertebral bodies using the human exon 7B
probe (data not shown), demonstrating the species and se-
quence specificity of the antisense riboprobes used.
Transcripts containing exon 6 were not detected in human
fetal chondrocytes at 38–42 days and at 42–44 days (Fig. 5, A
and B). It is interesting that exon 6-containing transcripts were
also not expressed by week 11 chondrocytes but were found in
week 28 cartilage and tendon (Fig. 4). In human, expression of
exon 6 transcripts may be restricted to later developmental
stages, unlike the mouse where exon 6-containing mRNAs were
clearly found in mouse fetal chondrocytes at 16.5 days (Fig. 5C)
and at 1 day postpartum (Fig. 4). The expression of mRNAs
containing exon 6 by mouse fetal chondrocytes is in contrast to
another study where most of the mouse Col11a-2 mRNAs in
3-week-old neonate cartilage lacked exon 6, and expression was
found mainly in non-chondrogenic tissues such as muscle,
brain, heart, and calvaria (15). However, exon 6 mRNAs were
reported in developing forelimb bud in embryos between 10 and
FIG. 3. Expression of alternatively
spliced exons between exons 5 and 7
in the human COL11A2 gene. Top and
center, RT-PCR analyses were of RNA iso-
lated from human week 11 and 28 fetal
cartilage (Ca) and from week 28 fetal ten-
don (Te). RT-PCR products were obtained
from reactions priming between exons 5
and 7C (panel A) and exons 5 and 7A
(panel B). Photographs of RT-PCR frag-
ments separated on ethidium bromide-
stained 2.5% (w/v) agarose gels are shown
on the extreme left panels, and the auto-
radiograms of Southern hybridizations
are to the right. Probes used for hybrid-
ization are indicated above each panel.
The plus signs indicate reactions with
added reverse transcriptase; the minus
signs indicate control reactions without
added reverse transcriptase. The absence
of PCR products and hybridization signal
for control reactions show fragments that
were not the result of amplification of
genomic DNA. The sizes and exon compo-
sition of the RT-PCR fragments are
shown to the right of the autoradiograms.
Bottom, schematic diagram showing the
exon-intron organization and locations of
hybridization probes (horizontal bars)
and oligonucleotide primers (arrows; see
“Experimental Procedures”). Exons 5–7,
open and numbered patterned boxes. Ab-
breviations: E, EcoRI; Ps, PstI; Y, XbaI;H,
HindIII.
FIG. 4. Expression of alternatively spliced exons between ex-
ons 5 and 7 in the mouse Col11a-2 gene. Top, RT-PCR analyses
were of RNA isolated from 1-day-old neonatal mouse cartilage (Ca) and
from a whole mouse embryo 15.5-days postcoitus (dpc). Left, photo-
graphs of RT-PCR fragments separated on ethidium bromide-stained
2.5% (w/v) agarose gel. Right, autoradiograms of Southern hybridiza-
tions using human genomic fragment pVL5E1 (see Fig. 3) as probe. Plus
signs indicate reactions with added reverse transcriptase; minus signs
indicate control reactions without added reverse transcriptase. Right,
sizes and exon composition of RT-PCR fragments. Bottom, diagram of
exons 5–7 (numbered open and patterned boxes) and the locations of
primers used for RT-PCR (arrows; see “Experimental Procedures”).
Abbreviations: Ps, PstI; Y, XbaI; B, BamHI.
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14 days. Differences in our findings may reflect stage-specific
transient expression of alternative transcripts containing exon
6.
Exon 7A and 7B probes hybridized to chondrogenic tissues
such as the chondrocytes within the cartilagenous masses
within vertebral bodies in both human and mouse (Fig. 5, D–I).
The sensitivity of in situ hybridization is usually insufficient
for the detection of splicing precursors. The strong hybridiza-
tion signals for these exons suggest that the inclusion of exons
7A and 7B in transcripts is the result of alternative splicing
and does not represent intermediates of mRNA processing.
Expression of transcripts containing exon 7B may be stage-
specific for human, since exon 7B could only be detected in
mRNAs at earlier stages of embryonic development (summa-
rized in Table II). In contrast for the mouse, exon 7B was
expressed throughout chondrogenesis from 13.5 days onward2
(this study).
Synthesis of a Truncated a2(XI) Amino-propeptide—Al-
though the relative levels of the different exon 7 variants were
not determined, it is interesting that exon 7C contains a con-
served purine-rich sequence 59-GAAGAGGAAGAA-39 (Fig. 2),
which is similar to that found to act as an exon splicing en-
hancer in some alternatively spliced genes (for review, see Refs.
31–33). Purine-rich motifs within exons have also been shown
to act as splicing silencers in viral genes (34). Exons 7A and 7B
also contained purine-rich motifs, but these were shorter. It
would be important to determine if these motifs have a role in
regulating usage of the alternative exon 7 splice sites.
The presence of premature termination codons in genes has
been shown to accelerate the decay rate of mRNAs, a phenom-
enon called nonsense-mediated mRNA decay (35, 36). Skipping
of exons containing a premature termination codon has also
been observed for fibrillin and ornithine d-aminotransferase
genes (37). The presence of the premature termination codon in
mRNAs that include exon 7A and 7B therefore raises questions
about the stability and the efficiency of translation of these
transcripts and whether levels of the truncated pro-a2(XI)
polypeptide may be low. An additional question would be
whether the premature termination affects splice site selection
frequency. The in situ hybridization data did not show an
especially low level of exon 7A- or exon 7B-containing tran-
scripts in human and mouse. The presence of the termination
codon therefore probably had not affected mRNA stability.
Although the physiologic significance of the synthesis of trun-
TABLE II
Developmental stage expression of mRNAs containing exons
6, 7A, 7B, and 7C in human and mouse
ND, not determined; dpc, days postcoitum; dpp, days postpartum; 1,
expressed; 2, not expressed.
Developmental stage
Exon expressed
6 7A 7B 7C
Human
38–42 daysa 2 1 1 ND
42–44 daysa 2 1 1 ND
11 weeksb 2 1 2 1
28 weeksb 1 1 2 1
Mouse
15.5 dpca,b 1 1 1 1
16.5 dpca 1 1 1 ND
1 dppb 1 1 1 1
a Determined by in situ hybridization.
b Determined by RT-PCR.
FIG. 5. Expression of alternatively spliced exons 6, 7A, and 7B in human and mouse embryos. Panels A–C, D–F, and G–I are
hybridizations with antisense riboprobes for exons 6, 7A, and 7B, respectively. Each panel was photographed under the same magnification under
dark-field illumination. There was a lack of exon 6 expression in vertebral bodies (vb, outlined by dashed line) in a week 38–42 (panel A) and week
42–44 human embryo but strong hybridization in a day 16.5 mouse fetus (C). There was strong expression of exons 7A and 7B in the vertebral
bodies of a day 38–42 (panels D and G) and 42–44 (panels E and H) human embryo and in a day 16.5 mouse fetus (panels F and I). Bar 5 50 mm.
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cated a2(XI) collagen is unknown, the synthesis of truncated
a2(XI) collagen chain may be important since it is conserved
among different species. Another question arising would be
whether the PARP peptide previously thought to be a processed
product of a2(XI) procollagen (38) is the product of mRNAs
encoding a truncated pro-a chain. This truncated polypeptide,
although larger, includes the PARP domain, and PARP peptide
could be derived from it by further processing.
Heterogeneity within the Amino-propeptide of a2(XI) Procol-
lagen Created by Alternative Splicing—Our data have shown
by RT-PCR and in situ hybridization analyses that the splice
signals present in intron 6 are utilized in both human and
mouse, giving rise to additional splice variants of a2(XI) pro-
collagen mRNA. Interestingly, the expression of exons 6 and 7B
may be developmental stage-specific in human (Table II). In
addition to the alternatively spliced exons 6, 7A, and 7B iden-
tified in the present study, exons 7C and 8 have also been
shown to be alternatively spliced in the mouse (15). With the
exception of the alternative transcripts that encode truncated
a2(XI) procollagen, the added differential usage of these exons
could generate great diversity in the structure of the amino-
propeptide of a2(XI) procollagen and therefore in heterotri-
meric type XI procollagen.
Several functions have been proposed for the amino-propep-
tide of fibril-forming collagens. Proposals based on studies on
types I and III procollagen include a role of retained propeptide
in preventing premature fibril formation intracellularly and in
regulating fibril diameter (39, 40). Biosynthetic studies have
shown that parts of the amino-propeptides of pro-a1(XI) and
pro-a2(XI) are retained within fibrils (41, 42), which may be
important for their proposed roles in regulating fibrillogenesis
and modulating fibril diameter (43–45).
It is also interesting that the amino-propeptides of type I and
III procollagen have been shown to be capable of down-regu-
lating collagen synthesis by cultured fibroblasts and in cell-free
translation assays (39, 46, 47). The possible synthesis of trun-
cated amino-propeptide for a2(XI) procollagen raises further
questions about potential roles for these polypeptides in regu-
lating biosynthesis at the translational level.
The complex alternative splicing found for the a1(XI) and
a2(XI) collagen genes with its resulting structural diversity
within the amino-terminal region and the developmental stage
differences in expression raise questions about possible differ-
ing functional roles for the amino-propeptide. The roles are
expected to differ depending on whether the amino-propeptide
is retained, cleaved, or synthesized as a separate polypeptide.
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